#BEGIN_DRUGCARD DB04457

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
902-04-5

# ChEBI_ID:
16192

# Chemical_Formula:
C10H14N5O7P

# Chemical_IUPAC_Name:
{[(2R,3S,5R)-5-(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy}phosphonic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
2'-Deoxyguanosine-5'-Monophosphate

# HET_ID:
DGP

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C10H14N5O7P/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(16)5(22-6)2-21-23(18,19)20/h3-6,16H,1-2H2,(H2,18,19,20)(H3,11,13,14,17)/t4-,5+,6+/m0/s1

# InChI_Key:
InChIKey=LTFMZDNNPPEQNG-KVQBGUIXSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00362

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4457

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
347.2212

# Molecular_Weight_Mono:
347.063084339

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1TLC

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.9

# Predicted_LogS:
-2.1

# Predicted_Water_Solubility:
2.67e+00 g/l

# Primary_Accession_No:
DB04457

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
65059

# PubChem_Substance_ID:
46507156

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01182

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NC1=NC(=O)C2=C(N1)N(C=N2)[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:21 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
X03016

# Drug_Target_1_GenBank_ID_Protein:
15387

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
1

# Drug_Target_1_Gene_Sequence:
>726 bp
ATGAAACTAATCTTTTTAAGCGGTGTAAAGCGTAGTGGAAAAGATACTACTGCTGATTTT
ATCATGAGCAATTATTCTGCAGTTAAATACCAACTTGCTGGTCCTATTAAGGATGCATTG
GCTTATGCATGGGGAGTATTTGCAGCAAACACTGACTATCCTTGCTTAACTCGTAAAGAG
TTTGAAGGAATTGACTATGATCGTGAGACTAATTTAAATCTGACTAAATTAGAAGTAATC
ACGATTATGGAACAAGCATTTTGTTATCTTAATGGTAAAAGCCCAATTAAAGGTGTGTTT
GTTTTTGATGACGAAGGAAAAGAATCAGTTAATTTCGTAGCATTTAATAAGATTACTGAC
GTTATAAATAATATTGAAGATCAATGGTCAGTCCGTCGTCTGATGCAAGCCCTAGGTACG
GATTTGATTGTTAATAACTTCGACCGCATGTACTGGGTAAAATTATTTGCTTTAGATTAT
CTTGATAAATTTAACTCAGGTTATGATTATTATATCGTTCCTGATACCCGTCAAGATCAT
GAAATGGATGCGGCTAGGGCGATGGGTGCTACAGTAATTCATGTAGTTCGTCCTGGTCAA
AAATCCAATGATACACATATTACAGAAGCTGGATTGCCAATTCGTGATGGCGATTTAGTA
ATTACAAACGATGGTTCTCTTGAAGAACTTTTTTCTAAAATTAAAAATACACTAAAGGTA
CTATAA

# Drug_Target_1_General_Function:
Involved in (deoxy)nucleoside-phosphate kinase activity

# Drug_Target_1_General_References:
12626685	Miller ES, Kutter E, Mosig G, Arisaka F, Kunisawa T, Ruger W: Bacteriophage T4 genome. Microbiol Mol Biol Rev. 2003 Mar;67(1):86-156, table of contents.
2740234	Koch T, Lamm N, Ruger W: Sequencing, cloning and overexpression of genes of bacteriophage T4 between map positions 74.325 and 77.184. Nucleic Acids Res. 1989 Jun 12;17(11):4392.
4057254	Broida J, Abelson J: Sequence organization and control of transcription in the bacteriophage T4 tRNA region. J Mol Biol. 1985 Oct 5;185(3):545-63.
7063418	Herrmann R: Nucleotide sequence of the bacteriophage T4 gene 57 and a deduced amino acid sequence. Nucleic Acids Res. 1982 Feb 11;10(3):1105-12.
8670851	Teplyakov A, Sebastiao P, Obmolova G, Perrakis A, Brush GS, Bessman MJ, Wilson KS: Crystal structure of bacteriophage T4 deoxynucleotide kinase with its substrates dGMP and ATP. EMBO J. 1996 Jul 15;15(14):3487-97.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3596

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
27329

# Drug_Target_1_Name:
Deoxynucleotide monophosphate kinase

# Drug_Target_1_Number_of_Residues:
241

# Drug_Target_1_PDB_ID:
1DEL

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
Not Available

# Drug_Target_1_Protein_Sequence:
>Deoxynucleotide monophosphate kinase
MKLIFLSGVKRSGKDTTADFIMSNYSAVKYQLAGPIKDALAYAWGVFAANTDYPCLTRKE
FEGIDYDRETNLNLTKLEVITIMEQAFCYLNGKSPIKGVFVFDDEGKESVNFVAFNKITD
VINNIEDQWSVRRLMQALGTDLIVNNFDRMYWVKLFALDYLDKFNSGYDYYIVPDTRQDH
EMDAARAMGATVIHVVRPGQKSNDTHITEAGLPIRDGDLVITNDGSLEELFSKIKNTLKV
L

# Drug_Target_1_Reaction:
ATP + deoxynucleoside phosphate = ADP + deoxynucleoside diphosphate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Acts on dGMP, dTMP and 5-hydroxymethyl-dCMP while excluding dCMP and dAMP

# Drug_Target_1_SwissProt_ID:
P04531

# Drug_Target_1_SwissProt_Name:
DNMK_BPT4

# Drug_Target_1_Synonyms:
DNK
EC 2.7.4.13
Gp1
dNMP kinase

# Drug_Target_1_Theoretical_pI:
4.85

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasm

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
J01710

# Drug_Target_2_GenBank_ID_Protein:
147987

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
thyA

# Drug_Target_2_Gene_Sequence:
>795 bp
ATGAAACAGTATTTAGAACTGATGCAAAAAGTGCTCGACGAAGGCACACAGAAAAACGAC
CGTACCGGAACCGGAACGCTTTCCATTTTTGGTCATCAGATGCGTTTTAACCTGCAAGAT
GGATTCCCGCTGGTGACAACTAAACGTTGCCACCTGCGTTCCATCATCCATGAACTGCTG
TGGTTTCTGCAGGGCGACACTAACATTGCTTATCTACACGAAAACAATGTCACCATCTGG
GACGAATGGGCCGATGAAAACGGCGACCTCGGGCCAGTGTATGGTAAACAGTGGCGCGCC
TGGCCAACGCCAGATGGTCGTCATATTGACCAGATCACTACGGTACTGAACCAGCTGAAA
AACGACCCGGATTCGCGCCGCATTATTGTTTCAGCGTGGAACGTAGGCGAACTGGATAAA
ATGGCGCTGGCACCGTGCCATGCATTCTTCCAGTTCTATGTGGCAGACGGCAAACTCTCT
TGCCAGCTTTATCAGCGCTCCTGTGACGTCTTCCTCGGCCTGCCGTTCAACATTGCCAGC
TACGCGTTATTGGTGCATATGATGGCGCAGCAGTGCGATCTGGAAGTGGGTGATTTTGTC
TGGACCGGTGGCGACACGCATCTGTACAGCAACCATATGGATCAAACTCATCTGCAATTA
AGCCGCGAACCGCGTCCGCTGCCGAAGTTGATTATCAAACGTAAACCCGAATCCATCTTC
GACTACCGTTTCGAAGACTTTGAGATTGAAGGCTACGATCCGCATCCGGGCATTAAAGCG
CCGGTGGCTATCTAA

# Drug_Target_2_General_Function:
Nucleotide transport and metabolism

# Drug_Target_2_General_References:
10944209	Erlanson DA, Braisted AC, Raphael DR, Randal M, Stroud RM, Gordon EM, Wells JA: Site-directed ligand discovery. Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9367-72.
1518803	Kim CW, Michaels ML, Miller JH: Amino acid substitution analysis of E. coli thymidylate synthase: the study of a highly conserved region at the N-terminus. Proteins. 1992 Aug;13(4):352-63.
2128651	Perry KM, Fauman EB, Finer-Moore JS, Montfort WR, Maley GF, Maley F, Stroud RM: Plastic adaptation toward mutations in proteins: structural comparison of thymidylate synthases. Proteins. 1990;8(4):315-33.
2223754	Montfort WR, Perry KM, Fauman EB, Finer-Moore JS, Maley GF, Hardy L, Maley F, Stroud RM: Structure, multiple site binding, and segmental accommodation in thymidylate synthase on binding dUMP and an anti-folate. Biochemistry. 1990 Jul 31;29(30):6964-77.
3520484	Finch PW, Wilson RE, Brown K, Hickson ID, Tomkinson AE, Emmerson PT: Complete nucleotide sequence of the Escherichia coli recC gene and of the thyA-recC intergenic region. Nucleic Acids Res. 1986 Jun 11;14(11):4437-51.
6308660	Belfort M, Maley G, Pedersen-Lane J, Maley F: Primary structure of the Escherichia coli thyA gene and its thymidylate synthase product. Proc Natl Acad Sci U S A. 1983 Aug;80(16):4914-8.
7708505	Voeller DM, Changchien LM, Maley GF, Maley F, Takechi T, Turner RE, Montfort WR, Allegra CJ, Chu E: Characterization of a specific interaction between Escherichia coli thymidylate synthase and Escherichia coli thymidylate synthase mRNA. Nucleic Acids Res. 1995 Mar 11;23(5):869-75.
8312270	Fauman EB, Rutenber EE, Maley GF, Maley F, Stroud RM: Water-mediated substrate/product discrimination: the product complex of thymidylate synthase at 1.83 A. Biochemistry. 1994 Feb 15;33(6):1502-11.
8973201	Sage CR, Rutenber EE, Stout TJ, Stroud RM: An essential role for water in an enzyme reaction mechanism: the crystal structure of the thymidylate synthase mutant E58Q. Biochemistry. 1996 Dec 17;35(50):16270-81.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9416600	Strop P, Changchien L, Maley F, Montfort WR: Crystal structures of a marginally active thymidylate synthase mutant, Arg 126-->Glu. Protein Sci. 1997 Dec;6(12):2504-11.
9826509	Reyes CL, Sage CR, Rutenber EE, Nissen RM, Finer-Moore JS, Stroud RM: Inactivity of N229A thymidylate synthase due to water-mediated effects: isolating a late stage in methyl transfer. J Mol Biol. 1998 Dec 4;284(3):699-712.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2626

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
30480

# Drug_Target_2_Name:
Thymidylate synthase

# Drug_Target_2_Number_of_Residues:
264

# Drug_Target_2_PDB_ID:
2KCE

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00303	Thymidylat_synt

# Drug_Target_2_Protein_Sequence:
>Thymidylate synthase
MKQYLELMQKVLDEGTQKNDRTGTGTLSIFGHQMRFNLQDGFPLVTTKRCHLRSIIHELL
WFLQGDTNIAYLHENNVTIWDEWADENGDLGPVYGKQWRAWPTPDGRHIDQITTVLNQLK
NDPDSRRIIVSAWNVGELDKMALAPCHAFFQFYVADGKLSCQLYQRSCDVFLGLPFNIAS
YALLVHMMAQQCDLEVGDFVWTGGDTHLYSNHMDQTHLQLSREPRPLPKLIIKRKPESIF
DYRFEDFEIEGYDPHPGIKAPVAI

# Drug_Target_2_Reaction:
5,10-methylenetetrahydrofolate + dUMP = dihydrofolate + dTMP

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Provides the sole de novo source of dTMP for DNA biosynthesis. This protein also binds to its mRNA thus repressing its own translation

# Drug_Target_2_SwissProt_ID:
P0A884

# Drug_Target_2_SwissProt_Name:
TYSY_ECOLI

# Drug_Target_2_Synonyms:
EC 2.1.1.45
TS
TSase

# Drug_Target_2_Theoretical_pI:
5.94

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB04457
